SEROQUEL PATENT EXPIRES ON September 26, 2011 !

Discussion in 'AstraZeneca' started by Anonymous, Aug 17, 2009 at 11:51 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    does anyone know when will the crestor patent expire? any idea if Teva has a plan?
     

  2. Anonymous

    Anonymous Guest

    There are many studies going around claiming this is true, and Im not intelligent, so don't worry about that. But my psychiatrist did get here medical degree at Harvard University.
     
  3. Anonymous

    Anonymous Guest

    My psychiatrist went to Harvard University, and good luck to you.
     
  4. Anonymous

    Anonymous Guest

    Check the Orange Book, google the word Orange Book in google.com. Its the book of patent expiration dates.
     
  5. Anonymous

    Anonymous Guest

    it doesnt matter when it expires, it's when teva or some indian company decides to challenge it
     
  6. Anonymous

    Anonymous Guest

    I am an in-the-know position at headquarters. Seroquel IR is to be off-patent in Q1 2012. Only the top sales force will remain, mostly people that AZ doesn't want to give up to other pharma Cies.
    Reps are currently asked to drive Seroquel XR performance, and I would strongly recommend that they do so: Bipolar Disorder and MDD in Feb 2010...all of this is being supported by huge investments in DTC, including Print and TV Ads, so poor performance will NOT be tolerated.
    Mark my words. All the best in 2010.
     
  7. Anonymous

    Anonymous Guest

    This is obviously a lie because there is no top sales force. COE winners today can be let go tomorrow if they are in the wrong place at the wrong time. Never mind though because the clock is ticking on all of us and sooner or later we will all end in the same place. Remember when PSSs worked to become DSMs and DSMs worked to become RSDs. Well those days are gone for good.
     
  8. Anonymous

    Anonymous Guest

    "Poor performance will NOT be tolerated", huh? The damn sales data is so inaccurate it's not even worth discussing! AZ knows, that if they lay off the wrong person because their "sales" are low, they could be in for a legal confrontation, because they KNOW it's inaccurate. IMS has had numerous problems over the years that's public knowledge. I know a couple of reps that have the money to really push something if they had that crap piled on them.

    Tell me, what's to become of XR when Seroquel and Zyprexa go generic in 2011?
     
  9. Anonymous

    Anonymous Guest

    5% market share. Maybe.
     
  10. Anonymous

    Anonymous Guest

    Judging from every other product, they'll 1) sue the fuck out of any generic manufacturer to extend the patent for at least two years. Then 2) They'll make an exclusivity deal with a selected generic company and take 1/2 or more of the profits and the price will stay high because there's still no real market competition.

    Just look at Toprol-XL. It's fucking Lopressor, generic 20 years ago, and still AZ has its hand in the jar up to its elbow. The only people fucked by the "generic" threat are the reps.
     
  11. Anonymous

    Anonymous Guest

    Seroquel pays up for off label uses $500,000,000 damnnnnnnnnn
     
  12. Anonymous

    Anonymous Guest

    Actually there is a study showing less sedation with xr compared to IR. A simple search on Az s site will reveal it. I am amazed how negative all you people are. Just put a fucking bullet in you head and get it over with. Gee Whiz! Get off your ass and work instead of whining.
     
  13. Anonymous

    Anonymous Guest

    Regarding growing out of bipolar, my wife had the response, "Why I grew out of it before I was diagnosed!"
     
  14. Anonymous

    Anonymous Guest


    Yeah, get out and work. Work for a company that paid a fine of $355 million for Zoladex medicare fraud, and still kept those few corrupt employees that participated in the fraud, including MW ( then So. Florida DSM) and PP (then Onc specialty rep, whose doc spilled all the beans to the Feds). In fact promotions were their rewards. Needless to say, a number of AZ innocents were canned in that process. Not one AZ exec was accused or prosecuted.
    Same story for Seoquel, the Fed was happy to get their $520 million, and no exec from AZ bit the dust (as usual).
    Money for lives and lies...it's OK, even as we, the AZ reps are paying for it with our incredible pay raises and huge bonus's (?) Why worry as long as our beloved and highly disiplined and motivated mangement keep their jobs and make those well deserved bonuses, Heil AZ!
     
  15. Anonymous

    Anonymous Guest

    Did you mean "when does the patient expire", or "when does the patent expire?"
    Both questions are relevant.
     
  16. Anonymous

    Anonymous Guest

    Oh?!?!? My father only got worse as he got older....
     
  17. Anonymous

    Anonymous Guest

    maybe he's "Sigmund FRAUD"!
     
  18. Anonymous

    Anonymous Guest

    Any advice for interview prep for psychiatric sales?
     
  19. Anonymous

    Anonymous Guest

    3 MONTHS AND COUNTING
     
  20. Anonymous

    Anonymous Guest

    Seroquel, an atypical antipsychotic manufactured by AstraZeneca, was originally supposed to go generic in the United States in 2011, but has since received a pediatric exclusivity extension. This means that the patent holder submitted an application to the FDA to extend the use of the drug to the pediatric population, in order to get its patent expiration date pushed back. This is often done to maximize the profitability of a drug that is not really intended to be marketed for pediatric use, most famously when Pfizer applied for such an extension for its erectile dysfunction drug, Viagra. The patent for Seroquel, also known as Ketipinor and Quetiapine, has already expired elsewhere, and generic versions of the drug are being sold in other countries, but thanks to this patent extension, none will be available in the United States before March 26, 2012